Loading clinical trials...
Loading clinical trials...
This study was conducted to investigate the effects of daily supplementation of L. plantarum APsulloc 331261(GTB1TM) on improvement of IBS symptoms.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Amorepacific Corporation
NCT06612411 · Irritable Bowel Syndrome with Diarrhea, Purine Metabolism Disorder
NCT07103772 · Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea, and more
NCT03729271 · Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea
NCT06432569 · Irritable Bowel Syndrome With Diarrhea
NCT04855799 · Ulcerative Colitis, Healthy, and more
Amorepacific
Yongin-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions